Scholars Central

Review articlePublished 21 Jul 2016

Emerging drugs for atrial fibrillation

Authors: David Singh, Steven Singh

Clinical Practice

Volume 7 · Issue 2 · Pages 125

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Atrial fibrillation is associated with excess morbidity and mortality, especially in the elderly. There are two approaches to the management of patients with atrial fibrillation: rate control or maintenance of sinus rhythm with antiarrhythmic medications. Depending on a patient’s risk profile, both strategies may require anticoagulation. Management of atrial fibrillation may be challenging owing to side effects associated with drugs such as warfarin and antiarrhythmic agents. However, there are currently ongoing efforts to develop newer, safer and more tolerable drugs to treat this nuisance arrhythmia. This article deals with the emerging drugs as potential targets for the management of atrial fibrillation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “David Singh”
  • BylineArticles whose byline prints “Steven Singh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels